Table 7.
Multi-organ affectation in COVID-19 patients; simultaneous histopathological findings.
| Total No of cases | No of cases with histopathological findings/Total No of cases analyzed, % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lung | Heart | Liver | Kidneys | Lymph nodes | CNS | Trachea | Spleen | Bone marrow | Testis | Muscle | |
| Lung (68) | 48/64 75% | 51/63 80.95% | 40/63 63.49% | 42/44 95.45% | 9/10 90% | 28/44 63.63% | 25/63 39.68% | 24/52 46.15% | 9/31 29.03% | 2/50 4% | |
| Heart (48) | 48/48100% | 40/47 85.10% | 35/40 87.5% | 36/37 97.29% | 9/10 90% | 25/38 65.78% | 20/47 42.55% | 15/43 34.88% | 9/29 31.01% | 0/40 0% | |
| Liver (51) | 51/51100% | 41/49 83.67% | 36/49 73.46% | 38/39 97.43% | 9/10 90% | 28/39 71.79% | 21/48 43.75% | 18/44 40.9% | 1/5 20% | 0/42 0% | |
| Kidney (40) | 40/40100% | 34/40 85% | 37/40 92.5% | 31/32 96.87% | 9/10 90% | 23/34 67.64% | 21/40 52.5% | 17/36 47.22% | 6/23 26.05% | 1/34 2.94% | |
| Lymph nodes (42) | 42/42100% | 36/42 85.71% | 38/40 95% | 31/40 77.5% | 7/8 87.75% | 24/37 64.86% | 17/40 42.5% | 12/37 32.43% | 7/28 25% | 1/38 2.63% | |
| CNS (9) | 9/9100% | 7/9 77.77% | 9/9100% | 9/9100% | 7/7100% | 7/7100% | 5//9 55.55% | 3/7 42.85% | 2/4 50% | 0/7 0% | |
| Trachea (28) | 28/8100% | 26/27 96.29% | 27/28 96,42% | 24/28 85.71% | 24/25 96% | 7/8 87.5% | 16/28 57.14% | 9/23 39.13% | 6/20 30% | 0/25 0% | |
| Spleen (25) | 25/25100% | 21/24 87.5% | 22/24 91.68% | 22/25 88% | 17/19 89.47% | 5/6 83.33% | 16/20 80% | 12/21 57.14% | 2/9 22.22% | 2/21 9.52% | |
| Bone marrow (24) | 24/24100% | 13/24 54.16% | 20/23 86.95% | 18/21 85.71% | 12/12100% | 3/4 75% | 8/10 80% | 12/22 54.54% | 1/8 12.5% | 2/21 9.52% | |
| Testis (9) | 9/9100% | 7/7100% | 7/7100% | 6/7 85.71% | 6/6100% | 2/2100% | 5/7 71.42% | 3/7 42.85% | 2/6 33.33% | 0/6 0% | |
| Muscle (2) | 2/2100% | 0/2 0% | 1 (2) 50% | 1 (2) 50% | 1 (1) 100% | 0 | 0 | 1 (1) 100% | 2/2100% | 0 | |